References
Wright, A. E.: On the need for abandoning much in immunology that has been regarded as assured. Proceedings of the Royal Society of Medicine 1941, 35, 161–186.
Yourtee, E. L., Root, R. K.: Antibiotic-neutrophil interactions in microbial killing. In: Gallin, J. I., Fauci, A. S. (eds.): Advances in host defense mechanisms. Raven Press, New York, 1982, p. 187–209.
Mandell, L. A.: Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbicidal function of the polymorphonuclear leukocyte. Reviews of Infectious Diseases 1982, 4: 683–697.
Hauser, W. E., Remington, J. S.: The effect of antibiotics on the humoral and cell-mediated immune responses. In: Sabath, L. D. (ed.): Antibiotics in the patient. Hans Huber, in press.
Tylewska, S., Hjertén, S., Wadstrom, T.: Effect of subinhibitory concentrations of antibiotics on the adhesion ofStreptococcus pyogenes to pharyngeal epithelial cells. Infection and Immunity 1981, 20: 563–566.
Ofek, I., Beachey, E. H., Eisenstein, B. I., Alkan, M. L., Sharon, N.: Suppression of bacterial adherence by subminimal inhibitory concentrations of β-lactam and aminoglycoside antibiotics. Reviews of Infectious Diseases 1979, 1: 832–837.
Vosbeck, K., Mett, H., Huber, U., Bohn, J., Petignat, M.: Effects of low concentrations of antibiotics onEscherichia coli adhesion. Antimicrobial Agents and Chemotherapy 1982, 21: 864–869.
Sandberg, T., Stenqvist, K., Svanborg-Edén, C.: Effects of subminimal inhibitory concentrations of ampicillin, chloramphenicol, and nitrofurantoin on the attachment ofEscherichia coli to human uroepithelial cells in vitro. Reviews of Infectious Diseases 1979, 1: 838–844.
Väisänen, V., Lounatmaa, K., Korhonen, T. K.: Effects of sublethal concentrations of antimicrobial agents on the hemagglutination, adhesion, and ultrastructure of pyelonephritogenicEscherichia coli strains. Antimicrobial Agents and Chemotherapy 1982, 22: 120–127.
Bernard, J., Francioli, P., Glauser, M. P.: Vancomycin prophylaxis of experimentalStreptococcus sanguis: inhibition of bacterial adherence rather than bacterial killing. Journal of Clinical Investigation 1981, 68: 1113–1116.
Gemmell, C. G., Peterson, P. K., Schmeling, D., Kim, Y., Matthews, J., Wannamaker, L., Quie, P. G.: Potentiation of opsonization and phagocytosis ofStreptococcus pyogenes following growth in the presence of clindamycin. Journal of Clinical Investigation 1981, 67: 1249–1256.
Root, R. K., Isturiz, R., Molavi, A., Metcalf, J. A., Melech, H. L.: Interactions between antibiotics and human neutrophils in the killing of staphylococci: studies with normal and cytochalasnβ-treated cells. Journal of Clinical Investigation 1981, 67: 247–259.
McDonald, P. J., Wetherall, B. L., Pruul, H.: Postantibiotic leukocyte enhancement: increased susceptibility of baczeria pretreated with antibiotics to activity of leukocytes. Reviews of Infectious Diseases 1981, 3: 38–44.
Dutcher, B. S., Reynard, A. M., Beck, M. E., Cunningham, R. K.: Potentiation of antibiotic bactericidal activity by normal human serum. Antimicrobial Agents and Chemotherapy 1978, 13: 820–826.
Fierer, J., Finley, F.: Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli. Journal of Infectious Diseases 1979, 140: 581–589.
Alexander, W. J., Cobbs, C. G., Curtiss, R.: Modification of bacterial serum susceptibility by rifampin. Infection and Immunity 1980, 28: 923–926.
Taylor, P. W., Gaunt, H., Unger, F. M.: Effect of subinhibitory concentrations of mecillinam on the serum susceptibility ofEscherichia coli strains. Antimicrobial Agents and Chemotherapy 1981, 19: 786–788.
Mandell, G. L.: Interaction of intraleukocytic bacteria and antibiotics. Journal of Clinical Investigation 1973, 52: 1673–1679.
Johnson, J. D., Hand, W. L., Francis, J. B., King-Thompson, N., Corwin, R. W.: Antibiotic uptake by alveolar macrophages. Journal of Laboratory and Clinical Medicine 1980, 95: 429–439.
Prokesch, R. C., Hand, W. L.: Antibiotic entry into human polymorphonuclear leukocytes. Antimicrobial Agents and Chemotherapy 1982, 21: 373–380.
Klempner, M. S., Styrt, B.: Clindamycin uptake by human neutrophils. Journal of Infectious Diseases 1981, 144: 472–479.
Jacobs, R. F., Wilson, C. B., Laxton, J. G., Haas, J. E., Smith, A. L.: Cellular uptake and intraccllular activity of antibiotics againstHaemophilus influenzae type b. Journal of Infectious Diseases 1982, 145: 152–159.
Friedman, H., Warren, G. H.: Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin. Proceedings of the Society for Experimental Biology and Medicine 1974, 146: 707–711.
Beam, T. R., Allen, J. C.: Amelioration of experimental bacterial meningitis by levamisole: evidence of a direct effect on the infecting bacteria. Journal of Infectious Diseases 1980, 142: 72–76.
Donabedian, H., Alling, D. W., Gallin, J. I.: Levamisole is inferior to placebo in the hyperimmunoglobulin E recurrent-infection (Job's) syndrome. New England Journal of Medicine 1982, 307: 290.
Forsgren, A., Banck, G.: Influence of antibiotics on lymphocyte function in vitro. Infection 1978, 6, Supplement 1: 91–97.
Bellahsene, A., Forsgren, A.: Effect of rifampin on the immune response in mice. Infection and Immunity 1980, 27: 15–20.
Shirley, S. F., Little, J. R.: Immunopotentiating effects of amphotericin B. I. Enhanced contact sensitivity in mice. Journal of Immunology 1979, 123: 2878–2882.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peterson, P.K. How antibiotics augment host defenses. Eur. J, Clin. Microbiol. 1, 335–337 (1982). https://doi.org/10.1007/BF02019930
Issue Date:
DOI: https://doi.org/10.1007/BF02019930